| 2.4 0.245 (11.37%) | 10-24 14:56 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 3.61 |
1-year : | 5.02 |
| Resists | First : | 3.09 |
Second : | 4.3 |
| Pivot price | 2.93 |
|||
| Supports | First : | 1.14 |
Second : | 0.95 |
| MAs | MA(5) : | 2.76 |
MA(20) : | 2.68 |
| MA(100) : | 2.68 |
MA(250) : | 3.51 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 21.7 |
D(3) : | 33.1 |
| RSI | RSI(14): 50.5 |
|||
| 52-week | High : | 6.3 | Low : | 1.02 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ EUDA ] has closed above bottom band by 32.3%. Bollinger Bands are 83.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 17 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 2.62 - 2.64 | 2.64 - 2.66 |
| Low: | 2.08 - 2.1 | 2.1 - 2.12 |
| Close: | 2.13 - 2.16 | 2.16 - 2.18 |
EUDA Health Limited develops digital health platform that offers virtual consults for non-emergency medical issues. The company was founded in 2019 and is based in Singapore. EUDA Health Limited company operates as a subsidiary of Watermark Developments Limited.
Fri, 24 Oct 2025
Is EUDA Health Holdings Limited stock dividend yield sustainable - Trade Entry Report & Expert Curated Trade Setup Alerts - newser.com
Fri, 24 Oct 2025
Strategies to average down on EUDA Health Holdings Limited - 2025 EndofYear Setup & AI Driven Stock Movement Reports - newser.com
Fri, 24 Oct 2025
Published on: 2025-10-24 05:41:11 - newser.com
Fri, 24 Oct 2025
Strategies to average down on EUDA Health Holdings Limited - July 2025 Snapshot & Daily Entry Point Alerts - newser.com
Fri, 24 Oct 2025
What risks investors should watch in EUDA Health Holdings Limited stock - 2025 Key Lessons & Weekly Top Stock Performers List - newser.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 38 (M) |
| Shares Float | 18 (M) |
| Held by Insiders | 49.5 (%) |
| Held by Institutions | 2.2 (%) |
| Shares Short | 99 (K) |
| Shares Short P.Month | 63 (K) |
| EPS | 0.01 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.11 |
| Profit Margin | 5.1 % |
| Operating Margin | -37.1 % |
| Return on Assets (ttm) | -64 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 60.2 % |
| Gross Profit (p.s.) | 0.03 |
| Sales Per Share | 0.13 |
| EBITDA (p.s.) | -0.06 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | 129.5 |
| PEG Ratio | 0 |
| Price to Book value | -25.9 |
| Price to Sales | 18.95 |
| Price to Cash Flow | -49.16 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |